Drug Profile
Research programme: epilepsy therapies - NsGene
Alternative Names: Ns G0501Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator NsGene
- Class Gene therapies; Neuropeptides
- Mechanism of Action Galanin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Epilepsy
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Epilepsy in Denmark (Implant)
- 06 Aug 2010 Preclinical trials in Epilepsy in Denmark (Intraparenchymal)